title: Fecal calprotectin-guided dosing of mesalamine in ulcerative colitis: concept proved but more data needed.
authors.affiliation: Division of Gastroenterology, University of California San Diego, La Jolla, California; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven - University of Leuven, Leuven, Belgium; Robarts Clinical Trials, Western University, London, Ontario, Canada.
authors.forename: Niels
authors.initials: N
authors.lastname: Vande Casteele
authors.affiliation: Division of Gastroenterology, University of California San Diego, La Jolla, California; Robarts Clinical Trials, Western University, London, Ontario, Canada.
authors.forename: William J
authors.initials: WJ
authors.lastname: Sandborn
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005243:Feces / Q000737:chemistry*; D006801:Humans; D039841:Leukocyte L1 Antigen Complex / Q000032:analysis*; D008297:Male; D019804:Mesalamine / Q000008:administration & dosage*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D039841:Leukocyte L1 Antigen Complex; D019804:Mesalamine